Ignatius Roger, MD
Surgery of the Hand · New York, NYNPI 1699832667
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Kerecis Limited at 34.8% of the total. Reporting peaked in 2022 at $184 and has fallen 72.5% since, to $51 in 2025. That places this record below the midpoint for surgery of the hand clinicians in NY, where the typical reported total is $1,726.
Across 15 payments — averaging $40.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$209
- DJO, LLC$113
- Endo Pharmaceuticals Inc.$85
- Pacira Therapeutics, Inc.$56
- Stryker$51
- Axogen$33
- plus $55 from 3 others
What the payments were for
- Food & beverage$601100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 2 | $209 |
| DJO, LLC | 1 | $113 |
| Endo Pharmaceuticals Inc. | 4 | $85 |
| Pacira Therapeutics, Inc. | 3 | $56 |
| Stryker | 1 | $51 |
| Axogen | 1 | $33 |
| Zyla Life Sciences, Inc. | 1 | $25 |
| Anika Therapeutics, Inc. | 1 | $16 |
| Acumed LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$601 in reported general payments places this provider in the 35th percentile of 40 surgery of the hand providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 20 | $571 |
| Gabapentin | 69 | $358 |
| Meloxicam | 117 | $301 |
| Naproxen | 24 | $72 |
Paid to pharmacies, not to this prescriber.
Other surgery of the hand in New York
- Melvin RosenwasserNew York$613K
- Karan DuaNew York$49K
- Sheel SharmaNew York$9K
- Amy BirnbaumNew York$5K
- Robert StrauchNew York$3K
- Abidemi AdenikinjuNew York$3K
- Rajendra KadiyalaNew York$2K
- David ChiuNew York$2K
- Glenn BeckerNew York$868
- Steven FernNew York$516
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.